Sandesh Mahatme
2015
In 2015, Sandesh Mahatme earned a total compensation of $2.4M as Executive Vice President, Chief Financial Officer and Chief Business Officer at Sarepta Therapeutics, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,331 |
|---|---|
| Option Awards | $1,309,997 |
| Salary | $456,664 |
| Stock Awards | $371,910 |
| Other | $61,190 |
| Total | $2,365,091 |
Mahatme received $1.3M in option awards, accounting for 55% of the total pay in 2015.
Mahatme also received $165.3K in non-equity incentive plan, $456.7K in salary, $371.9K in stock awards and $61.2K in other compensation.
Rankings
In 2015, Sandesh Mahatme's compensation ranked 4,069th out of 13,638 executives tracked by ExecPay. In other words, Mahatme earned more than 70.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,069 out of 13,638 | 70th |
Division Manufacturing | 1,484 out of 5,187 | 71st |
Major group Chemicals And Allied Products | 542 out of 1,857 | 71st |
Industry group Drugs | 430 out of 1,531 | 72nd |
Industry Pharmaceutical Preparations | 337 out of 1,179 | 71st |
Source: SEC filing on April 27, 2017.
Mahatme's colleagues
We found four more compensation records of executives who worked with Sandesh Mahatme at Sarepta Therapeutics in 2015.